1: Treatment of atrial fibrillation and paroxysmal supraventricular tachycardia with bidisomide. The Atrial Fibrillation Investigation with Bidisomide (AFIB) Investigators. Circulation. 1997 Oct 21;96(8):2625-32. PubMed PMID: 9355903.
2: Pao LH, Zhou SY, Cook C, Kararli T, Kirchhoff C, Truelove J, Karim A, Fleisher D. Reduced systemic availability of an antiarrhythmic drug, bidisomide, with meal co-administration: relationship with region-dependent intestinal absorption. Pharm Res. 1998 Feb;15(2):221-7. PubMed PMID: 9523307.
3: Martin CL, Palomo MA, Mcmahon EG. Comparison of bidisomide, flecainide and dofetilide on action potential duration in isolated canine atria: effect of isoproterenol. J Pharmacol Exp Ther. 1996 Jul;278(1):154-62. PubMed PMID: 8764346.
4: Cook CS, Ames GB, Smith ME, Kowalski KG, Karim A. Absorption and disposition of a new antiarrhythmic agent bidisomide in man. Pharm Res. 1993 Nov;10(11):1675-82. PubMed PMID: 8290484.
5: Komori S, Sano S, Li BH, Matsumura K, Naitoh A, Mochizuki S, Ishihara T, Watanabe A, Umetani K, Ijiri H, et al. Effects of bidisomide (SC-40230), a new class I antiarrhythmic agent, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats; comparison with mexiletine and disopyramide. Heart Vessels. 1995;10(1):7-11. PubMed PMID: 7537263.
6: Homma N, Tsujimoto G, Hashimoto K. Electrophysiologic effects of an antiarrhythmic agent, bidisomide, on sodium current in isolated rat ventricular myocytes: comparison with mexiletine and disopyramide. Jpn J Pharmacol. 2001 May;86(1):23-31. PubMed PMID: 11430469.
7: Cook CS, Lonien M, Hribar J. Effect of diet and gavage on the dose- and dose-mode-dependent absorption and metabolism of bidisomide in rat. Xenobiotica. 2000 May;30(5):523-33. PubMed PMID: 10875685.
8: Lee KH, Xu GX, Schoenhard GL, Cook CS. Mechanisms of food effects of structurally related antiarrhythmic drugs, disopyramide and bidisomide in the rat. Pharm Res. 1997 Aug;14(8):1030-8. PubMed PMID: 9279885.
9: Cook CS, McDonald SJ, Karim A. Importance of pharmacokinetic and physicochemical data in the discovery and development of novel anti-arrhythmic drugs. Xenobiotica. 1993 Nov;23(11):1299-309. PubMed PMID: 8310713.
10: Vandenberghe Y, Masson M, Palate B, Roba J. Effect of folate supplementation on clinical chemistry and hematologic changes related to bidisomide administration in the rat. Drug Chem Toxicol. 1995 Nov;18(4):235-70. PubMed PMID: 8586020.
11: Cook CS, Zhang L, Osis J, Schoenhard GL, Karim A. Mechanism of compound- and species-specific food effects of structurally related antiarrhythmic drugs, disopyramide and bidisomide. Pharm Res. 1998 Mar;15(3):429-33. PubMed PMID: 9563073.
12: Cook CS, Ames GB, Hribar JD, Liu NW, Sweeney DL, Schoenhard GL, Karim A. Metabolism of a novel antiarrhythmic agent, bidisomide, in man: use of high resolution mass spectrometry to distinguish desisopropyl bidisomide from desacetyl bidisomide. Xenobiotica. 1995 Sep;25(9):981-91. PubMed PMID: 8553691.
13: Hackett AM, Gardiner P, Garthwaite SM. The effect of bidisomide (SC-40230), a new class Ia/Ib antiarrhythmic agent, on defibrillation energy requirements in dogs with healed myocardial infarctions. Pacing Clin Electrophysiol. 1993 Feb;16(2):317-26. PubMed PMID: 7680461.
14: Zhenjiu W, Awaji T, Hirasawa A, Motomura S, Hashimoto K. Effects of a new class I antiarrhythmic drug bidisomide on canine ventricular arrhythmia models. Mol Cell Biochem. 1993 Feb 17;119(1-2):159-69. PubMed PMID: 8455577.
15: Schmidt JJ, Frederick LG, Garthwaite SM. Rapid infusions of bidisomide or disopyramide in conscious dogs: effect of myocardial infarction on acute tolerability. J Cardiovasc Pharmacol. 1992 Aug;20(2):236-50. PubMed PMID: 1381015.
16: Page RL, Wharton JM, Wilkinson WE, Friedman IM, Claypool WD, Karim A, Kowalski KG, McDonald SJ, Gardiner P, Pritchett EL. Bidisomide (SC-40230), a new antiarrhythmic agent: initial study of tolerability and pharmacokinetics. Clin Pharmacol Ther. 1992 Apr;51(4):371-8. PubMed PMID: 1563207.
17: Rogister A, Vandenberghe Y, Roba J. Deoxyuridine suppression test on isolated rat bone marrow cells and the in vitro effect of bidisomide. Toxicol In Vitro. 1994 Apr;8(2):277-82. PubMed PMID: 20692917.
18: Skanchy DJ, Xie GH, Tait RJ, Luna E, Demarest C, Stobaugh JF. Application of sulfobutylether-beta-cyclodextrin with specific degrees of substitution for the enantioseparation of pharmaceutical mixtures by capillary electrophoresis. Electrophoresis. 1999 Sep;20(13):2638-49. PubMed PMID: 10532329.
19: Kowalski KG, Karim A. A semicompartmental modeling approach for pharmacodynamic data assessment. J Pharmacokinet Biopharm. 1995 Jun;23(3):307-22. PubMed PMID: 8834198.
20: Frederick LG, McDonald SJ, Garthwaite SM. Cardiovascular profile of a new anti-arrhythmic agent, SC-40230. Cardiovasc Res. 1989 Oct;23(10):897-903. PubMed PMID: 2620317.